Evidence map›Paper›PMID 32091043›Full record

ArticleBiomaterials science2020

Heparin-based hydrogel scaffolding alters the transcriptomic profile and increases the chemoresistance of MDA-MB-231 triple-negative breast cancer cells.

Nidhi Menon, Ha X Dang, Udaya Sree Datla, Maryam Moarefian, Christopher B Lawrence, Christopher A Maher, Caroline N Jones

Open access · hybridAbstract read
In one paragraph

Article in Biomaterials science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Nidhi MenonGraduate Program in Translational Biology, Medicine and Health, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061, USA. jonescn@vt.edu.
Ha X Dang
Udaya Sree Datla
Maryam Moarefian
Christopher B Lawrence
Christopher A Maher
Caroline N Jones
Translational Research in Oncology · FRJames S. McDonnell Foundation · USVirginia Tech · US

Funding

VT Initiative for Maximizing Student DiversityR25GM072767 · NIGMS · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI SMITH, EDWARD J · 2007 to 2021
$6.9M
Microsystems to Decipher Leukocyte Decision-MakingR35GM133610 · NIGMS · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI JONES, CAROLINE N. · 2019 to 2023
$1.8M
NIGMS NIH HHS R25 GM072767NIGMS NIH HHS R35 GM133610
6 · The paper itself

Abstract

The tumor microenvironment plays a critical role in the proliferation and chemoresistance of cancer cells. Growth factors (GFs) are known to interact with the extracellular matrix (ECM) via heparin binding sites, and these associations influence cell behavior. In the present study, we demonstrate the ability to define signals presented by the scaffold by pre-mixing growth factors, such as epidermal growth factor, into the heparin-based (HP-B) hydrogel prior to gelation. In the 3D biomimetic microenvironment, breast cancer cells formed spheroids within 24 hours of initial seeding. Despite higher number of proliferating cells in 2D cultures, 3D spheroids exhibited a higher degree of chemoresistance after 72 hours. Further, our RNA sequencing results highlighted the phenotypic changes influenced by solid-phase GF presentation. Wnt/β-catenin and TGF-β signaling were upregulated in the cells grown in the hydrogel, while apoptosis, IL2-STAT5 and PI3K-AKT-mTOR signaling were downregulated. With emerging technologies for precision medicine in cancer, this nature of fine-tuning the microenvironment is paramount for cultivation and downstream characterization of primary cancer cells and rare circulating tumor cells (CTCs), and effective screening of chemotherapeutic agents.

Indexed as

Antineoplastic Agents, PhytogenicBiomimetic MaterialsCell ProliferationDrug Screening Assays, AntitumorHeparinHumansHydrogelsPaclitaxelTranscriptomeTriple Negative Breast NeoplasmsTumor Cells, CulturedTumor MicroenvironmentAntineoplastic Agents, PhytogenicHeparinHydrogelsPaclitaxel

Identifiers

PMID32091043
PMCPMC7497406
OpenAlexW3005620080

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.